Your browser doesn't support javascript.
loading
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Br J Cancer ; 101(8): 1456-60, 2009 Oct 20.
Article in En | MEDLINE | ID: mdl-19707196

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Genes, p53 / Genes, BRCA1 / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / Genes, BRCA2 / Proto-Oncogene Proteins c-mdm2 / Mutation Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2009 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Genes, p53 / Genes, BRCA1 / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / Genes, BRCA2 / Proto-Oncogene Proteins c-mdm2 / Mutation Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2009 Type: Article Affiliation country: France